- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Olodaterol (BI 1744)
Total 1382 results
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation
-
Boehringer IngelheimCompletedAsthmaAustria, Germany, Poland, Romania, Slovakia, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Austria, Canada, France, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, China, Germany, Taiwan
-
Boehringer IngelheimCompletedAsthmaUnited States, Canada, France, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, South Africa, Spain, Sweden, Thailand, Ukraine
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited States, Canada, Germany, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
Boehringer IngelheimCompletedAsthmaUnited States, Austria, Germany, Hungary, Slovakia, Slovenia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Germany, Hungary
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Chugai PharmaceuticalCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Netherlands, Norway
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, China, Germany, New Zealand, Taiwan
-
Boehringer IngelheimRecruitingMelanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)Netherlands
-
Avidity Biosciences, Inc.Enrolling by invitationDuchenne Muscular Dystrophy | DMD | Exon 44 | DuchenneUnited States
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Boehringer IngelheimWithdrawnAnal Canal Squamous Cell CarcinomaKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingCardiovascular DiseasesKorea, Republic of
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted